Xenetic Biosciences(XBIO.US)

Last Updated 19:00:00 ET
longbridge loading

Xenetic Biosciences | 8-K: FY2026 Q1 Revenue: USD 800 K

Earnings Watch·
US
XBIO
+3.70%
Earnings Watch·
US
XBIO
+3.70%

Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform | XBIO Stock News

StockTitan·
US
XBIO
+3.70%
US
VHT
+0.64%
US
FBT
+0.69%
StockTitan·
US
XBIO
+3.70%
US
VHT
+0.64%
US
FBT
+0.69%

Xenetic Biosciences | 10-Q: FY2026 Q1 Revenue: USD 806.92 K

Earnings Watch·
US
XBIO
+3.70%
Earnings Watch·
US
XBIO
+3.70%

Xbrane Sets April–May Target to Resubmit Ranibizumab Biosimilar BLA to U.S. FDA

Tip Ranks·
US
XBIO
+3.70%
US
BBH
+0.64%
US
PBE
+0.35%
Tip Ranks·
US
XBIO
+3.70%
US
BBH
+0.64%
US
PBE
+0.35%

Xenetic Biosciences | 8-K: FY2025 Revenue: USD 3 M

Earnings Watch·
US
XBIO
+3.70%
Earnings Watch·
US
XBIO
+3.70%

Xenetic Biosciences | 10-K: FY2025 Revenue: USD 2.976 M

Earnings Watch·
US
XBIO
+3.70%
Earnings Watch·
US
XBIO
+3.70%

Kuros Biosciences Hits Record Sales and First Profit as MagnetOs Fuels Global Expansion

Tip Ranks·
US
BIB
+1.41%
US
XBI
+0.81%
US
PBE
+0.35%
Tip Ranks·
US
BIB
+1.41%
US
XBI
+0.81%
US
PBE
+0.35%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
FBT
+0.69%
US
SBIO
+1.84%
US
HUM
-0.14%
benzinga_article·
US
FBT
+0.69%
US
SBIO
+1.84%
US
HUM
-0.14%
© 2026 Longbridge｜Disclaimer